Skip to main content

ABCD Nationwide Oral Semaglutide Audit Publications

Papers, abstracts, presentations, posters and webcasts emanating from the audit



Published papers



Slides from presentations




Thomas S.J. Crabtree, Karen Adamson, Senthilkumar Krishnasamy, May Thin Khine, Parijat De, Rajesh Peter, Robert E. Ryder. Glucose and weight outcomes associated with oral semaglutide in the real-world: Initial results from the Association of British Clinical Diabetologists’ (ABCD) audit. ADA 2023, Diabetes 2023;72(Supplement_1):787-P.

Link to abstract:


ADA 2023 ePoster
ADA 2023


The ABCD nationwide semaglutide audit is an independent audit supported by an unrestricted grant from Novo Nordisk